← All indications
Multiple Organ Failure
A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.
Drugs by status
Phase 4 trials (8)
Phase 3 trials (9)
Phase 2 trials (10)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (11)
- ZonMw: The Netherlands Organisation for Health Research and Development
- Shahid Beheshti University of Medical Sciences
- Maastricht University
- Harvard University
- Sanquin
- Utrecht University
- University of Athens
- Hellenic Institute for the Study of Sepsis
- University of Texas, Galveston
- European Commission
- American Burn Association
Organization Involved with Phase 2 Indications (24)
- Servier
- AM-Pharma
- Athersys, Inc
- Faron Pharmaceuticals Ltd
- S-Evans Biosciences Co.,Ltd.
- Bakirkoy Dr. Sadi Konuk Research and Training Hospital
- Aarhus University
- Memorial Hermann Health System
- Radboud University
- University of Leicester
- University of Southern Denmark
- Aalborg University
- University of Cincinnati
- University of Copenhagen
- University of Turku
- Zhejiang University
- Department of Defense
- National Taiwan University
- University of Texas at Houston
- Martin Luther University
- Koordinierungszentren für Klinische Studien bzw. Zentren für klinische Studien
- University of Helsinki
- Istinye University
- Liv Hospital (Ulus)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (4)